Detrol: Effective Relief for Overactive Bladder Symptoms
Detrol
| Product dosage: 1mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.00 (0%) | 🛒 Add to cart |
| 60 | $1.15 | $82.00 $69.00 (16%) | 🛒 Add to cart |
| 90 | $1.08 | $123.00 $97.00 (21%) | 🛒 Add to cart |
| 120 | $1.05 | $164.00 $126.00 (23%) | 🛒 Add to cart |
| 180 | $1.01 | $246.00 $182.00 (26%) | 🛒 Add to cart |
| 270 | $0.99 | $369.00 $267.00 (28%) | 🛒 Add to cart |
| 360 | $0.98
Best per pill | $492.00 $353.00 (28%) | 🛒 Add to cart |
| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.20 | $66.00 (0%) | 🛒 Add to cart |
| 60 | $1.85 | $132.00 $111.00 (16%) | 🛒 Add to cart |
| 90 | $1.74 | $198.00 $157.00 (21%) | 🛒 Add to cart |
| 120 | $1.68 | $264.00 $202.00 (23%) | 🛒 Add to cart |
| 180 | $1.62 | $396.00 $292.00 (26%) | 🛒 Add to cart |
| 270 | $1.58 | $594.00 $427.00 (28%) | 🛒 Add to cart |
| 360 | $1.56
Best per pill | $792.00 $562.00 (29%) | 🛒 Add to cart |
| Product dosage: 4mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.67 | $110.00 (0%) | 🛒 Add to cart |
| 60 | $2.85 | $220.00 $171.00 (22%) | 🛒 Add to cart |
| 90 | $2.57 | $330.00 $231.00 (30%) | 🛒 Add to cart |
| 120 | $2.42 | $440.00 $291.00 (34%) | 🛒 Add to cart |
| 180 | $2.28 | $660.00 $411.00 (38%) | 🛒 Add to cart |
| 270 | $2.20
Best per pill | $990.00 $593.00 (40%) | 🛒 Add to cart |
Synonyms | |||
Detrol (tolterodine tartrate) is a prescription medication specifically formulated to manage the symptoms of overactive bladder (OAB). As an antimuscarinic agent, it works by relaxing the bladder muscle, thereby reducing urinary urgency, frequency, and incontinence episodes. This medication is designed for adults seeking long-term control over disruptive bladder symptoms, allowing for improved daily functioning and quality of life. Clinical studies support its efficacy and safety profile when used as directed under medical supervision.
Features
- Active ingredient: tolterodine tartrate
- Available in 1 mg and 2 mg extended-release tablets
- Also offered in immediate-release form (Detrol LA not applicable here)
- Prescription-only medication
- Manufactured under strict pharmaceutical quality standards
Benefits
- Reduces sudden, strong urges to urinate
- Decreases the number of times you need to urinate daily
- Helps prevent accidental urine leakage (urge incontinence)
- Improves ability to complete tasks without frequent bathroom breaks
- Enhances sleep quality by reducing nighttime urination
- Supports greater confidence in social and work settings
Common use
Detrol is primarily prescribed for the management of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. It is indicated for adults who experience these symptoms due to detrusor muscle overactivity. The medication is not intended for use in pediatric populations and should be administered only after proper diagnostic evaluation by a healthcare provider to confirm overactive bladder diagnosis.
Dosage and direction
The recommended dosage for Detrol is 2 mg twice daily for most patients. For patients with impaired liver function or those taking certain CYP3A4 inhibitors, a reduced dosage of 1 mg twice daily is recommended. Tablets should be swallowed whole with water and may be taken with or without food. Dosage adjustments should only be made under medical supervision based on therapeutic response and tolerability. Treatment response is typically evaluated within 4-8 weeks of initiation.
Precautions
Patients should inform their healthcare provider of any history of urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. Use with caution in patients with clinically significant bladder outflow obstruction, gastrointestinal obstructive disorders, or renal impairment. Regular monitoring of residual urine volume may be recommended for patients with bladder outflow obstruction. Elderly patients may require closer supervision due to potential increased sensitivity to anticholinergic effects.
Contraindications
Detrol is contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. It should not be used by patients with known hypersensitivity to tolterodine tartrate or any components of the formulation. The medication is contraindicated in patients with myasthenia gravis or severe ulcerative colitis. Concomitant use with strong CYP3A4 inhibitors like ketoconazole requires dosage adjustment or alternative therapy.
Possible side effects
Common side effects may include dry mouth (experienced by approximately 23% of patients), headache (11%), constipation (7%), and abdominal pain (5%). Less frequently reported side effects include dry eyes, dyspepsia, somnolence, dizziness, and blurred vision. Serious but rare side effects may include urinary retention, angioedema, and QT prolongation. Patients should report any persistent or severe side effects to their healthcare provider promptly.
Drug interaction
Detrol may interact with other medications that inhibit CYP3A4 metabolism, including ketoconazole, itraconazole, clarithromycin, and ritonavir. Concomitant use with other anticholinergic agents may increase the frequency and severity of side effects. Caution is advised when using with medications that prolong QT interval. Moderate interactions may occur with fluoxetine and cyclosporine. Always inform your healthcare provider of all medications, including over-the-counter drugs and supplements.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one. Maintain regular dosing schedule to ensure consistent therapeutic effect. If multiple doses are missed, contact your healthcare provider for guidance on resuming therapy.
Overdose
In case of suspected overdose, seek immediate medical attention. Symptoms may include severe central anticholinergic effects such as blurred vision, dry mouth, difficulty urinating, and rapid heartbeat. Cardiovascular symptoms may include tachycardia and QT prolongation. Treatment is symptomatic and supportive. Activated charcoal may be administered if ingestion was recent. ECG monitoring is recommended in cases of significant overdose.
Storage
Store at room temperature (20-25°C or 68-77°F) in the original container. Keep tightly closed and protect from moisture and light. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Properly dispose of any unused medication through take-back programs or according to FDA guidelines.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting or changing any medication regimen. Individual results may vary based on specific health conditions and adherence to prescribed therapy. The prescribing physician should be consulted for personalized medical advice and treatment recommendations.
Reviews
Clinical studies demonstrate that approximately 70% of patients experience significant improvement in overactive bladder symptoms with Detrol therapy. Patients report average reduction of 50-60% in incontinence episodes and 30-40% decrease in daily urinary frequency. Many users note improved quality of life and reduced anxiety about bathroom accessibility. Some patients report dry mouth as a manageable side effect that often diminishes over time. Long-term users appreciate the consistent symptom control when taken as prescribed.